Airnguru and Piano Launch Bundle and Ancillaries Price Optimization Engine with SKY Airline 1-08-2023, 20:10

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26

Quantexa Partners with the Anti-Human Trafficking Intelligence Initiative (ATII) to Intensify the Fight Against Human Trafficking 11-01-2024, 18:00